Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients

Glioma is the most common and fatal primary brain tumor in humans. A significant role for long non-coding RNA (lncRNA) in glioma is the regulation of gene expression and chromatin recombination, and immunotherapy is a promising cancer treatment. Therefore, it is necessary to identify necroptosis-rel...

Full description

Bibliographic Details
Main Authors: Desheng Chen, Chao Dou, Haiyu Liu, Binshun Xu, Bowen Hu, Liangwen Kuang, Jiawei Yao, Yan Zhao, Shan Yu, Yang Li, Fuqing Wang, Mian Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.929233/full
_version_ 1818484657113530368
author Desheng Chen
Chao Dou
Haiyu Liu
Binshun Xu
Bowen Hu
Liangwen Kuang
Jiawei Yao
Yan Zhao
Shan Yu
Yang Li
Fuqing Wang
Mian Guo
author_facet Desheng Chen
Chao Dou
Haiyu Liu
Binshun Xu
Bowen Hu
Liangwen Kuang
Jiawei Yao
Yan Zhao
Shan Yu
Yang Li
Fuqing Wang
Mian Guo
author_sort Desheng Chen
collection DOAJ
description Glioma is the most common and fatal primary brain tumor in humans. A significant role for long non-coding RNA (lncRNA) in glioma is the regulation of gene expression and chromatin recombination, and immunotherapy is a promising cancer treatment. Therefore, it is necessary to identify necroptosis-related lncRNAs in glioma. In this study, we collected and evaluated the RNA-sequencing (RNA-seq) data from The Cancer Genome Atlas (TCGA, https://www.ncbi.nlm.nih.gov/, Data Release 32.0, March 29, 2022) glioma patients, and necroptosis-related lncRNAs were screened. Cox regression and least absolute shrinkage and selection operator (LASSO) analysis were performed to construct a risk score formula to explore the different overall survival between high- and low-risk groups in TCGA. Gene Ontology (GO) and pathway enrichment analysis (Kyoto Encyclopedia of Genes and Genomes (KEGG)) were performed to identify the function of screened genes. The immune correlation analysis showed that various immune cells and pathways positively associated with a patient’s risk score. Furthermore, the analysis of the tumor microenvironment indicated many immune cells and stromal cells in the tumor microenvironment of glioma patients. Six necroptosis-related lncRNAs were concerned to be involved in survival and adopted to construct the risk score formula. The results showed that patients with high-risk scores held poor survival in TCGA. Compared with current clinical data, the area under the curve (AUC) of different years suggested that the formula had better predictive power. We verified that necroptosis-related lncRNAs play a significant role in the occurrence and development of glioma, and the constructed risk model can reasonably predict the prognosis of glioma. The results of these studies added some valuable guidance to understanding glioma pathogenesis and treatment, and these necroptosis-related lncRNAs may be used as biomarkers and therapeutic targets for glioma prevention.
first_indexed 2024-12-10T15:58:00Z
format Article
id doaj.art-39f082e2559245ac830b145de86c5ee1
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-10T15:58:00Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-39f082e2559245ac830b145de86c5ee12022-12-22T01:42:34ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.929233929233Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patientsDesheng Chen0Chao Dou1Haiyu Liu2Binshun Xu3Bowen Hu4Liangwen Kuang5Jiawei Yao6Yan Zhao7Shan Yu8Yang Li9Fuqing Wang10Mian Guo11Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Pathology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaChina Pharmaceutical Enterprises Association, Heilongjiang, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, ChinaGlioma is the most common and fatal primary brain tumor in humans. A significant role for long non-coding RNA (lncRNA) in glioma is the regulation of gene expression and chromatin recombination, and immunotherapy is a promising cancer treatment. Therefore, it is necessary to identify necroptosis-related lncRNAs in glioma. In this study, we collected and evaluated the RNA-sequencing (RNA-seq) data from The Cancer Genome Atlas (TCGA, https://www.ncbi.nlm.nih.gov/, Data Release 32.0, March 29, 2022) glioma patients, and necroptosis-related lncRNAs were screened. Cox regression and least absolute shrinkage and selection operator (LASSO) analysis were performed to construct a risk score formula to explore the different overall survival between high- and low-risk groups in TCGA. Gene Ontology (GO) and pathway enrichment analysis (Kyoto Encyclopedia of Genes and Genomes (KEGG)) were performed to identify the function of screened genes. The immune correlation analysis showed that various immune cells and pathways positively associated with a patient’s risk score. Furthermore, the analysis of the tumor microenvironment indicated many immune cells and stromal cells in the tumor microenvironment of glioma patients. Six necroptosis-related lncRNAs were concerned to be involved in survival and adopted to construct the risk score formula. The results showed that patients with high-risk scores held poor survival in TCGA. Compared with current clinical data, the area under the curve (AUC) of different years suggested that the formula had better predictive power. We verified that necroptosis-related lncRNAs play a significant role in the occurrence and development of glioma, and the constructed risk model can reasonably predict the prognosis of glioma. The results of these studies added some valuable guidance to understanding glioma pathogenesis and treatment, and these necroptosis-related lncRNAs may be used as biomarkers and therapeutic targets for glioma prevention.https://www.frontiersin.org/articles/10.3389/fonc.2022.929233/fullgliomasimmuneTEMbiomarkernecroptosis-related lncRNAs
spellingShingle Desheng Chen
Chao Dou
Haiyu Liu
Binshun Xu
Bowen Hu
Liangwen Kuang
Jiawei Yao
Yan Zhao
Shan Yu
Yang Li
Fuqing Wang
Mian Guo
Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
Frontiers in Oncology
gliomas
immune
TEM
biomarker
necroptosis-related lncRNAs
title Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
title_full Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
title_fullStr Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
title_full_unstemmed Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
title_short Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients
title_sort comprehensive analysis necroptosis related lncrnas can effectively predict the prognosis of glioma patients
topic gliomas
immune
TEM
biomarker
necroptosis-related lncRNAs
url https://www.frontiersin.org/articles/10.3389/fonc.2022.929233/full
work_keys_str_mv AT deshengchen comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT chaodou comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT haiyuliu comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT binshunxu comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT bowenhu comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT liangwenkuang comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT jiaweiyao comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT yanzhao comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT shanyu comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT yangli comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT fuqingwang comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients
AT mianguo comprehensiveanalysisnecroptosisrelatedlncrnascaneffectivelypredicttheprognosisofgliomapatients